U.S. HLA typing transplant diagnostics services market by technology will reach USD 431.75 million by 2025 from USD 211.98 million with a CAGR of 9.4% in the forecast period of 2018 to 2025.
The major factors driving the market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the U.S. HLA typing transplant diagnostics services market.
The key market players for U.S. HLA typing transplant diagnostics services market are listed below;

Proimmune Ltd.
Creative Biolabs
Histogenetics LLC
The UCLA Immunogenetics Center
Admera Health
Quick Biology
New York Blood Center
The Sequencing Center
BloodCenter of Wisconsin
Laboratory Corporation of America Holdings

The market is further segmented into;
Technology
End-users

The U.S. HLA typing transplant diagnostics services market is segmented on the basis of technology and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The U.S. HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) is expected to dominate the U.S. HLA typing transplant diagnostics services market with 51.0% market share and is expected to reach USD 217.22 million by 2025, growing at a CAGR of 9.2% in the forecast period 2018 to 2025.
The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the U.S. HLA typing transplant diagnostics services market with 41.7% market share and is expected to reach USD 176.37 million by 2025, growing at a CAGR of 9.1% in the forecast period 2018 to 2025.
The U.S. HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals is expected to dominate the U.S. HLA typing transplant diagnostics services market with 36.3% market share and is expected to reach USD 159.84 million by 2025, growing at the highest CAGR of 9.7% in the forecast period 2018 to 2025.
Covered in this report
The report covers the present scenario and the growth prospects of the U.S. HLA typing transplant diagnostics services market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.